Pharmacometabonomics and personalized medicine (Q38124254)

29 August 2017

title

Pharmacometabonomics and personalized medicine (English)

1 reference

29 August 2017

main subject

personalized medicine

1 reference

2

Ruey Leng Loo

1 reference

29 August 2017

Jeremy R Everett

1

1 reference

29 August 2017

Francis S Pullen

series ordinal

3

1 reference

29 August 2017

publication date

25 July 2013

1 reference

Annals of Clinical Biochemistry

29 August 2017

published in

1 reference

29 August 2017

volume

50

1 reference

29 August 2017

issue

Pt 6

1 reference

29 August 2017

page(s)

523-545

1 reference

Systematic review of pharmacoeconomic studies of pharmacogenomic tests

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacogenomics: the inherited basis for interindividual differences in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacogenomics: unlocking the human genome for better drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacogenomics: a systems approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Cost effectiveness of pharmacogenomics: a critical and systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Translating pharmacogenomics: challenges on the road to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacoproteomics: a chess game on a protein field

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolomics – the link between genotypes and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolite profiling for plant functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Global systems biology, personalized medicine and molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Advances in structure elucidation of small molecules using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Liquid chromatography-mass spectrometry based global metabolite profiling: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Gas chromatography/mass spectrometry in metabolic profiling of biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Ambient desorption ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Orthogonal projections to latent structures (O-PLS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The in vivo and in vitro protective properties of taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolomics: a global biochemical approach to drug response and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Impact of intestinal microbiota on intestinal luminal metabolome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

XPB, a subunit of TFIIH, is a target of the natural product triptolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Methodological quality in pharmacogenetic studies with binary assessment of treatment response: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Human sulfotransferases and their role in chemical metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharma-metabolomics in neonatology: is it a dream or a fact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Serum molecular signatures of weight change during early breast cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Enteric microbiome metabolites correlate with response to simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacometabolomics reveals racial differences in response to atenolol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacometabonomics as an effector for personalized medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Symbiotic gut microbes modulate human metabolic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The withdrawal of torcetrapib from drug development: implications for the future of drugs that alter HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Personalised medicine: not just in our genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The human gut microbiome: the ghost in the machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Understanding the role of gut microbiome-host metabolic signal disruption in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The human gut microbiome: implications for future health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The gut microbiota as a target for improved surgical outcome and improved patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Gut microbiome-host interactions in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

A framework for human microbiome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Targeting the human genome-microbiome axis for drug discovery: inspirations from global systems biology and traditional Chinese medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Genomic variation landscape of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Novel biomarkers for pre-diabetes identified by metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolic phenotyping for monitoring surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Characterization of surgical aerosols by the compact single-particle mass spectrometer LAMPAS 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

In situ, real-time identification of biological tissues by ultraviolet and infrared laser desorption ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolic phenotyping in clinical and surgical environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Implementation of molecular phenotyping approaches in the personalized surgical patient journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Metabolomics as a tool for personalizing medicine: 2012 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Systematic functional analysis of the yeast genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Role of pharmacoproteomics in the development of personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Global metabolic profiling procedures for urine using UPLC–MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacometabonomic Characterization of Xenobiotic and Endogenous Metabolic Phenotypes That Account for Inter-individual Variation in Isoniazid-Induced Toxicological Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

Pharmacometabonomic Investigation of Dynamic Metabolic Phenotypes Associated with Variability in Response to Galactosamine Hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

The Footprints of Gut Microbial–Mammalian Co-Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213497929

21 January 2018

Identifiers

DOI

10.1177/0004563213497929

1 reference

29 August 2017

1 reference